68 Ga-PSMA PET/CT for the detection of bone metastases in prostate cancer: a systematic review of the published literature-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

68 Ga-PSMA PET/CT for the detection of bone metastases in prostate cancer: a systematic review of the published literature

Published:2017-10-29 Issue:6 Volume:38 Page:911-922
ISSN:1475-0961
Container-title:Clinical Physiology and Functional Imaging
language:en
Short-container-title:Clin Physiol Funct Imaging

Author:

Zacho Helle D.¹²^ORCID,Nielsen Julie B.¹²,Haberkorn Uwe³⁴,Stenholt Louise⁵,Petersen Lars J.¹²

Affiliation:

1. Department of Nuclear Medicine; Clinical Cancer Research Center; Aalborg University Hospital; Aalborg Denmark

2. Department of Clinical Medicine; Aalborg University; Aalborg Denmark

3. Department of Nuclear Medicine; University Hospital of Heidelberg; Heidelberg Germany

4. Clinical Cooperation Unit Nuclear Medicine; German Cancer Research Centre; Heidelberg Germany

5. Medical Library; Aalborg University Hospital; Aalborg Denmark

Publisher

Wiley

Subject

Physiology (medical),General Medicine,Physiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cpf.12480/fullpdf

Reference74 articles.

1. PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions;Afshar-Oromieh;Eur J Nucl Med Mol Imaging,2013

2. Comparison of PET/CT and PET/MRI hybrid systems using a 68Ga-labelled PSMA ligand for the diagnosis of recurrent prostate cancer: initial experience;Afshar-Oromieh;Eur J Nucl Med Mol Imaging,2014a

3. Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer;Afshar-Oromieh;Eur J Nucl Med Mol Imaging,2014b

4. The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer;Afshar-Oromieh;Eur J Nucl Med Mol Imaging,2015a

5. The theranostic PSMA ligand PSMA-617 in the diagnosis of prostate cancer by PET/CT: biodistribution in humans, radiation dosimetry, and first evaluation of tumor lesions;Afshar-Oromieh;J Nucl Med,2015b

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PSMA-PET/CT response after metastasis-directed radiotherapy of bone oligometastases in prostate cancer;EJNMMI Reports;2024-08-19

2. Assessing Response to PSMA Radiopharmaceutical Therapies with Single SPECT Imaging at 24 Hours After Injection;Journal of Nuclear Medicine;2024-05-09

3. Radiohybrid prostate-specific membrane antigen ligand: new frontier in prostate cancer imaging and therapy;Translational Andrology and Urology;2024-05

4. Impact of ⁶⁸Ga-PSMA PET/CT on Survival and Management in Prostate Cancer;Current Medical Imaging Formerly Current Medical Imaging Reviews;2024-04-26

5. PSMA PET/CT for Primary Staging of Prostate Cancer - An Updated Overview;Seminars in Nuclear Medicine;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3